Clinical trial
Safety Study of Idebenone to Treat Friedreich's Ataxia
NCT00015808 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00015808 |
|---|---|
| Title | Safety Study of Idebenone to Treat Friedreich's Ataxia |
| Official title | Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich's Ataxia |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Friedreich Ataxia |
| Intervention type | Drug |
| Interventions | Idebenone |
| Enrollment | 100 |
| Start date | May 1, 2001 |
| Completion | Apr 1, 2006 |
| First posted | May 7, 2001 |
| Last update posted | Jul 12, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: